Rhumbline Advisers Lensar, Inc. Transaction History

Rhumbline Advisers

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 01, 2024	SELL	$3.0 - $4.88 $111 - $180	-37 Reduced 6.89%	500 $2,000
Q2 2023 Aug 08, 2023	BUY	$2.3 - $4.34 $1,235 - $2,330	537 New	537 $2,000
Q2 2021 Aug 05, 2021	SELL	$6.87 - $8.66 $111,768 - $140,889	-16,269 Closed	0 $0
Q1 2021 May 06, 2021	SELL	$6.28 - $9.56 $1,268 - $1,931	-202 Reduced 1.23%	16,269 $118,000
Q4 2020 Feb 10, 2021	BUY	$6.7 - $12.2 $110,355 - $200,946	16,471 New	16,471 $119,000

4.89M

700

31.3K

Ticker LNSR
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 11,021,000
Market Cap $78M
Description
LENSAR, Inc., a commercial-stage medical device company, focuses on designing, developing, and marketing a femtosecond laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism. Its LENSAR Laser System incorporates a range of proprietary technologies designed to assist the surgeon in...

Get notified when there are updates to the investment portfolio of Rhumbline Advisers, based on Form 13F filings with the SEC.

Stay updated on Rhumbline Advisers with notifications on news.